RBC Bioscience Corporation (TPEX:6848)
21.30
-0.45 (-2.07%)
Sep 11, 2026, 2:05 PM CST
| Market Cap | 309.74M +17.9% |
| Revenue (ttm) | 220.60M +9.3% |
| Net Income | 21.06M +7.5% |
| EPS | 1.47 +8.0% |
| Shares Out | 14.27M |
| PE Ratio | 14.76 |
| Forward PE | n/a |
| Dividend | 3.53 (14.98%) |
| Ex-Dividend Date | Sep 2, 2026 |
| Volume | 29,035 |
| Open | 21.75 |
| Previous Close | 21.75 |
| Day's Range | 21.10 - 21.75 |
| 52-Week Range | 14.30 - 28.15 |
| Beta | 0.46 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Nov 13, 2026 |